Gender-affirming hormone therapy and autoimmunity: new insights from a 3-year follow-up study.
作者信息
Marconi Matteo, Riitano Gloria, Fisher Alessandra Daphne, Cocchetti Carlotta, Pagano Maria Teresa, Capozzi Antonella, Longo Agostina, D'Arienzo Sara, Vignozzi Linda, Sorice Maurizio, Ortona Elena, Pierdominici Marina
机构信息
Reference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.
Department of Experimental Medicine, Sapienza University, Rome, Italy.
出版信息
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxad122.
Abstract
摘要
相似文献
1
Gender-affirming hormone therapy and autoimmunity: new insights from a 3-year follow-up study.
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxad122.
2
HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort study.
Lancet HIV. 2025 Apr;12(4):e283-e292. doi: 10.1016/S2352-3018(25)00004-9. Epub 2025 Mar 27.
3
The impact of gender-affirming interventions on eating disorder diagnosis risk among transgender and gender-diverse individuals.
Commun Med (Lond). 2024 Dec 31;4(1):283. doi: 10.1038/s43856-024-00704-7.
4
Clinical outcomes of radiation therapy for transgender and gender-expansive people with cancer.
Front Oncol. 2023 Sep 7;13:1135400. doi: 10.3389/fonc.2023.1135400. eCollection 2023.
5
Prevalence of detransition in persons seeking gender-affirming hormonal treatments: a systematic review.
J Sex Med. 2025 Jan 9;22(2):356-368. doi: 10.1093/jsxmed/qdae186.
6
Development of a large Danish single-centre retro- and prospective transgender cohort using a web-based platform: a study protocol of a transgender cohort study.
BMJ Open. 2025 Jun 9;15(6):e091366. doi: 10.1136/bmjopen-2024-091366.
7
Gender-Affirming Surgery for Transgender and Gender Diverse Medicare Beneficiaries.
JAMA Netw Open. 2025 May 1;8(5):e258072. doi: 10.1001/jamanetworkopen.2025.8072.
8
Injectable Aesthetic Treatments for Improving Facial Skin Quality in Transgender Patients With or Without Gender-Affirming Hormone Therapy.
J Cosmet Dermatol. 2025 Sep;24 Suppl 4(Suppl 4):e70318. doi: 10.1111/jocd.70318.
9
The Power of Voice: The Role of Target Voice Achievement in Enhancing Quality of Life for Transgender Individuals in a Gender-Affirming Voice Management Lab, El Paso, Texas, 2016-2022.
J Voice. 2025 Jun 27. doi: 10.1016/j.jvoice.2025.06.004.
10
Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review.
Hormones (Athens). 2025 Jan 8. doi: 10.1007/s42000-024-00626-y.
引用本文的文献
1
Sex Bias in Autoimmunity: New Findings and New Opportunities.
JID Innov. 2025 Jun 20;5(5):100391. doi: 10.1016/j.xjidi.2025.100391. eCollection 2025 Sep.
2
Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy.
Front Immunol. 2025 Jan 16;15:1501364. doi: 10.3389/fimmu.2024.1501364. eCollection 2024.
本文引用的文献
1
Potential immunological effects of gender-affirming hormone therapy in transgender people - an unexplored area of research.
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139612. doi: 10.1177/20420188221139612. eCollection 2022.
2
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
3
Challenges of caring for transgender and gender diverse patients with rheumatic disease: presentation of seven patients and review of the literature.
Curr Opin Rheumatol. 2023 Mar 1;35(2):117-127. doi: 10.1097/BOR.0000000000000894. Epub 2022 Jul 5.
4
Sex Differences in Immunity.
Annu Rev Immunol. 2022 Apr 26;40:75-94. doi: 10.1146/annurev-immunol-101320-125133. Epub 2022 Jan 5.
5
Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review.
Semin Arthritis Rheum. 2022 Feb;52:151920. doi: 10.1016/j.semarthrit.2021.10.004. Epub 2021 Oct 28.
6
Non-organ-specific autoimmunity in adult 47,XXY Klinefelter patients and higher-grade X-chromosome aneuploidies.
Clin Exp Immunol. 2021 Sep;205(3):316-325. doi: 10.1111/cei.13616. Epub 2021 Jun 10.
7
The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome.
Antibodies (Basel). 2016 Jun 8;5(2):16. doi: 10.3390/antib5020016.
8
Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.
J Blood Med. 2019 Jul 10;10:209-216. doi: 10.2147/JBM.S166780. eCollection 2019.
9
Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications.
Reumatologia. 2018;56(4):243-248. doi: 10.5114/reum.2018.77976. Epub 2018 Aug 31.
10
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903. doi: 10.1210/jc.2017-01658.
Zotero 插件